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Critical Appraisal of Endometriosis
Management for Pain and Subfertility
N. F. Zuberi,J. H. Rizvi ( Department of Obstetrics and Gynaecology, The Aga Khan University,
Karachi. )

Introduction
Endometriosis can be seen as a continuum that is only considered pathological when a
certain threshold of severity has been reached.1 Minimal or mild endometriosis is
increasingly viewed as part of normal physiologic process, whereas the more severe
forms - ovarian cysts and deeply infiltrating lesions- are considered 'endometriotic
disease.2 Estimates from asymptomatic fertile subpopulations undergoing tubal ligation
have varied greatly, from 0.7 to 43% around a mean of 4%.3 However, up to 90% of
these women were diagnosed with minimal or mild endometriosis.
Understanding the environmental and genetic epidemiology of endometriosis is essential
for identification of appropriate subjects and effective therapy. Our understanding of
endometriosis is severely compromised as studies failed to take account of basic
epidemiological principles in their design. Of 100 studies of environmental risk-factors
reviewed by Eskenazi and Warner3, only six met the following basic criteria for adequate
study design:
(i) cohort or case-control design;
(ii) surgically confirmed cases;
(iii) clearly described criteria for control selection; and (iv) adjustment for confounding
factors in the analysis.
There is now good evidence that the assessments patients make about their health differ
from the proxy reports other health professionals make about their patients' well-being.4
It is important therefore to evaluate from the patients' perspective the ways in which
treatments are affecting their health-related quality of life. The areas of well-being and
functioning that may be important to women, with endometriosis that can lead to a
diminished quality of life, have been identified as: feelings of control and powerlessness,
unable to conceive, ineffectiveness of treatments, lack of social support, impaired sexual
functioning, lack of self image, lack of emotional well-being, pain, relationship with
children, performance at work place and dissatisfaction with medical professionals.5
These dimensions have previously been overlooked but are specific to the experiences of
women with endometriosis and should be taken in account when deciding about modality
of treatment. In this clinical review we will focus on treatment of pain and infertility
ascribable to endometriosis as they also influence other areas of well-being and
functioning which are important to women with endometriosis.

Methods
Our electronic searches targeted all therapeutic modalities among studies on treatment of
endometriosis. We searched general bibliographic databases: Medline (1966-2001) and
specialist computer databases: the Cochrane Library6, Bandolier7, Clinical Evidence8,
Database of Abstracts of Review of Effectiveness (DARE)9 and National Guideline
Clearinghouse (NGC).10 We also checked reference lists of known reviews and primary
articles to identify cited articles not captured by electronic searches.
The selection criteria were systemic reviews and randomized controlled trials (RCTs) in
treatment of pain and subfertility ascribable to endometriosis, Electronic searches were
scrutinised and full manuscripts were obtained of all citations that were likely to meet the
predefined criteria. Final inclusion or exclusion decisions were then made after
examining these manuscripts. In cases of duplicate publication we selected the most
recent and complete versions. Due to logistic reasons we restricted our search to English
language. In presenting this critical appraisal, we adopted the evidence-based approach of
formulating answerable clinical questions11 for different clinical possibilities.
Pain ascribable to endometriosis
Question 1.
In women with pain ascribable to endometriosis, does hormonal treatment at diagnosis
compared with placebo reduce pain?
Assessment of Search
See Table 1 for details.
Outcomes and Intervensions examined
For relief of pain, 6 months of continuous ovulation suppression was done using Danazol,
Gestrinone, Depot medroxyprogesterone acetate (DMPA), Dydrogesterone, Oral
contraceptives or GnRH-analogues
Critically appraised results
1. Dydrogestrone given at two different doses in the luteal phase, showed no evidence of
effect.
2. Combined oral contraceptives (COC) vs GnRH-analogues, no significant difference in
pain reduction was found.
1. Danazol (200 mg/day) vs Gestrinone (2.5 mg twice weekly), no significant difference
in pain reduction was found.
2. DMPA (150 mg q 3 months) vs COC+Danazol (50 mg/day), DMPA was more
effective at reducing dysmenorrhoea.
Answer
All hormonal treatments at diagnosis, except for dydrogesterone, reduce pain ascribable
to endometriosis compared with placebo, and are equally effective at 6-months
Question 2.

In women with pain ascribable to endometriosis, does laparoscopic uterine nerve ablation
(LUNA) compared with laparoscopic treatment without LUNA reduces pain?
Assessment of Search
See Table 1 for details.
Outcomes and Intervensions examined
For relief of pain, LUNA was compared with laparoscopic treatment without LUNA in
132 women, age range 18-40 years, with endometriosis of stages I-III in two RCTs.
Critically appraised results
1. No significant difference in pain relief between both groups.
2. Patient satisfaction was high in both groups (68 v 73%)
Answer
There is insufficient evidence at present on the effects of LUNA in women with pain
ascribable to endometriosis.(results awaited of ongoing study).
Question 3.
In women with pain ascribable to endometriosis, does laparoscopic ablation of
endometriotic deposits along with laparoscopic uterine nerve ablation (LUNA) compared
to diagnostic laparoscopy reduce pain?

Assessment of Search
See Table 1 for details.
Outcomes and Interventions examined
Reduced pain at 6 months after laparoscopic ablation plus LUNA was compared with
diagnostic laparoscopy in 63 women with mild to moderate endometriosis.
Critically appraised results
1. No RCT evaluating laparoscopic ablation of endometriotic deposits was found.
2. Median decrease in pain score of 2.85 for ablation was seen versus 0.05 for diagnostic
laparoscopy, p=0.01
Answer
Combined treatment with ablation of deposits plus LUNA reduces pain more than
diagnostic laparoscopy at 6 months.
Question 4.
In women with pain ascribable to endometriosis, does postoperative hormonal treatment

compared with placebo significantly reduces pain?
Assessment of Search
See Table 1 for details.
Outcomes and Interventions examined
Reduced pain at 6 months
Critically appraised results
1. Postoperative danazol (600mg/day) v placebo for 3 months, No significant difference
in pain relief 6 months after finishing treatment
2. Danazol 100 mg/day for 6 months v expectant management (after conservative surgery
followed by monthly injections of decapeptyl for 6 months), danazol significantly
reduced pain at 12 months and 24 months
3. Postoperative Danazol (600 mg/day) or Medroxyprogesterone (100 mg/day) for 180
days v placebo, more reduction in pain at 6 months with danazol
4. GnRH-analogues 6 months v placebo, significantly reduced pain scores and delayed
recurrence of pain by more than 12 months with GnRH-analogues.
Answer
Six-months of postoperative hormonal treatment verses placebo significantly reduces
pain and delays the recurrence of pain while treatment for 3 months did not seem to be
effective.
Question 5.
In women with pain ascribable to endometrioma, does laparoscopic cystectomy
compared with laparoscopic drainage of ovarian cyst significantly reduces pain?
Assessment of Search
See Table 1 for details.
Outcomes and Interventions examined
1 RCT evaluating comparison of laparoscopic cystectomy with laparoscopic drainage of
ovarian cyst was found.
Reduced recurrence of pain
Increased pain free interval after operation Critically appraised results
1. Laparoscopic cystectomy reduced pain at 2 years.
2. Laparoscopic cystectomy increased the pain free interval after operation (median
interval 19 months v 9.5 months; p value <0.05)
Answer

Laparoscopic cystectomy reduces pain more than laparoscopic drainage of
endometriomas. The recurrence rate of endometriomas after drainage /aspiration was
high.
Subfertility ascribable to endometriosis
Question 1.
In women with subfertility ascribable to endometriosis, does hormonal treatment at
diagnosis compared with placebo improve fertility?
Assessment of Search
See Table 2 for details.
Outcomes and Intervensions examined
Attempting conception for more than 12 months following 6 months treatment with
Danazol, Medroxyprogesterone, or Gonadorelin (GnRH) analogues.
Critically appraised results
1. Danazol vs Placebo, no significant effect on the likelihood of pregnancy was found.
2. Medroxyprogesterone vs Placebo, no significant effect on the likelihood of pregnancy
was found.
Answer
No evidence that hormonal treatments at diagnosis improve fertility.
Question 2.
In women with subfertility ascribable to endometriosis, does laparoscopic
ablation/excision of endometriotic deposits compared with diagnostic laparoscopy
improve fertility?
Assessment of Search
See Table 2 for details.
Outcomes and Interventions examined
Relative risk of pregnancy after 36 weeks or pregnancy rates at end of 12 months
following laparoscopic ablation/excision of mild to moderate endometriotic deposits.
Critically appraised results
1. In larger trial of 341 women, laparoscopic surgery significantly increased cumulative
pregnancy rates (follow-up of 36 weeks)
2. In a smaller more recent trial of 101 women, no significant difference in pregnancy
rates was found (follow-up of 12 months)
Answer
Laparoscopic ablation/excision of endometriotic deposits may improve fertility. (results

awaited of ongoing trials)
Question 3.
In women with moderate or severe endometriosis, does postoperative hormonal treatment
compared with placebo improve fertility?
Assessment of Search
See Table II for details.
Outcomes and Interventions examined
Pregnancy rates and time to conception.
Critically appraised results
1. For all stages of endometriosis no effect of postoperative hormonal therapy was found
on pregnancy rates and time to conception
Answer
No evidence of an effect of postoperative hormonal treatment on fertility.
Question 4.
In women with subfertility ascribable to endometrioma, does laparoscopic cystectomy
compared with laparoscopic drainage of ovarian cyst significantly improves fertility?
Assessment of Search
See Table 2 for details.
Outcomes and Intervensions examined
Pregnancy rates.
Critically appraised results
1. 1 RCT evaluating comparison of laparoscopic cystectomy with laparoscopic drainage
of ovarian cyst was found.
2. Laparoscopic cystectomy improved pregnancy rates after operation (67% v 24 %; p
value <0.05).
Answer
Laparoscopic cystectomy improves fertility more than laparoscopic drainage of
endometriomas.
Conclusions
Surgical resection of endometriosis, previously possible only by means of laparotomy,
can now be accomplished through laparoscopic techniques. There is a learning curve to
achieve these skills which can be accomplished. Treatment of adnexal masses by

operative laparoscopy can be performed safely, with reduced morbidity and patient
disability, and at a reduced cost.33 Although randomised control trials are lacking, a
recent critical appraisal showed laparoscopic surgery to be equivalent to laparotomy for
ovarian endometriosis.34 In a comparison of two surgical series for recurrent
endometriosis35 rate of recurrence of dyspareunia and need for third surgery was higher
in laparotomy series. While no significant difference was found between the cumulative
pregnancy rates at 24 months in the two groups.
Our review of current best available evidence for the management of endometriosis
strongly suggests an urgent need to modify conventional clinical practices in favour of
evidence-based practice recommendations.
Best Practice Points
1. Hormonal treatments (combined oral contraceptives, Danazol or Depot
medroxyprogesterone acetate) for pain are effective but should be used for six months.
2. Surgical treatments (ablation of endometriosis and LUNA) are effective treatments for
pain.
3. Pre or post hormonal treatments for subfertility are not useful - they do not improve
pregnancy rates.
4. The most effective treatment for endometriomas is Cystectomy or ablation of cyst wall
rather than aspiration or drainage.
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